The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled. Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Franchise litigation related to technology licenses for entertainment technology company
Represented an entertainment technology company regarding claims that it had unlawfully sold franchises in California in violation of state franchise more
Construction litigation for transportation company
Represent the public owner on the largest construction project undertaken in the United States. We have been working with the owner’s team, including more
Defense of breach of fiduciary duty claims and pursuit of insurance coverage for directors and officers of high-technology company and related investment funds
Defended former directors and officers of high-technology company and related investment funds against breach of fiduciary duty, fraud, and other more
Multi-family dispositions for Gables Residential
Representation of Gables Residential in the disposition of multi-family properties throughout the country. Representation in this project includes: more